InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

LENZ Therapeutics, Inc.

LENZ Clue Score42
United States Fiscal year ends December CIK 0001815776 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

30
Insider
Date
Role
Action
Shares
Price
Amount
Daniel R. Chevallard
27 Mar 2026
Chief Financial Officer
Buy
7,500
$8.57
$64.28K
Evert B. Schimmelpennink
27 Mar 2026
President, CEO and Secretary
Buy
28,089
$8.95
$251.41K
Jeffrey P. George
27 Mar 2026
Director
Buy
5,592
$8.92
$49.89K
Daniel R. Chevallard
7 Nov 2025
Chief Financial Officer
Buy
2,178
$22.76
$49.56K
Daniel R. Chevallard
7 Nov 2025
Chief Financial Officer
Buy
20
$22.71
$454.20
James W McCollum
7 Nov 2025
Director
Buy
10,500
$22.79
$239.28K
Daniel R. Chevallard
14 May 2024
Chief Financial Officer
Buy
3,188
$15.68
$49.99K
James W McCollum
13 May 2024
Director
Buy indirect
31,332
$15.99
$501.09K
Ra Capital Management, L.p.
21 Mar 2024
Director
Buy indirect
64,971
$15.03
left out
Ra Capital Management, L.p.
21 Mar 2024
Director
Buy indirect
933,038
$15.03
left out
Samsara BioCapital, L.P.
12 Apr 2022
10% owner
Buy indirect
350,000
$4.08
$1.43M
Phil Gutry
11 Apr 2022
Chief Business Officer
Buy
5,000
$4.01
$20.05K
Samsara BioCapital, L.P.
11 Apr 2022
10% owner
Buy indirect
74,464
$4.07
$303.07K
Samsara BioCapital, L.P.
24 Jan 2022
10% owner
Buy indirect
23,000
$8.70
$200.10K
Samsara BioCapital, L.P.
21 Jan 2022
10% owner
Buy indirect
100,000
$8.99
$899.00K
Samsara BioCapital, L.P.
20 Jan 2022
10% owner
Buy indirect
43,105
$8.92
$384.50K
Samsara BioCapital, L.P.
19 Jan 2022
10% owner
Buy indirect
54,565
$9.24
$504.18K
Samsara BioCapital, L.P.
15 Dec 2021
10% owner
Buy indirect
22,329
$10.19
$227.53K
Samsara BioCapital, L.P.
22 Nov 2021
10% owner
Buy indirect
201,685
$10.15
$2.05M
Samsara BioCapital, L.P.
15 Oct 2021
10% owner
Buy indirect
2,300
$12.49
$28.73K
Samsara BioCapital, L.P.
14 Oct 2021
10% owner
Buy indirect
3,100
$12.50
$38.75K
Samsara BioCapital, L.P.
13 Oct 2021
10% owner
Buy indirect
45,400
$13.22
$600.19K
Samsara BioCapital, L.P.
8 Oct 2021
10% owner
Buy indirect
75,000
$13.12
$984.00K
Samsara BioCapital, L.P.
7 Oct 2021
10% owner
Buy indirect
9,021
$14.94
$134.77K
Samsara BioCapital, L.P.
6 Oct 2021
10% owner
Buy indirect
61,475
$13.83
$850.20K
Samsara BioCapital, L.P.
29 Jun 2021
10% owner
Buy indirect
15,000
$17.00
$255.00K
Samsara BioCapital, L.P.
29 Jun 2021
10% owner
Buy indirect
485,000
$17.00
$8.25M
Smital Shah
29 Jun 2021
Director
Buy indirect
5,882
$17.00
$99.99K
Davis Jerel
29 Jun 2021
Director
Buy indirect
180,000
$17.00
$3.06M
Versant Venture Capital VI, L.P.
29 Jun 2021
10% owner
Buy indirect
180,000
$17.00
$3.06M
Show all 77 transactions →

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 37
Transactions with no price 2
Shares from compensation/vesting 39,830,610
History held since 28 Jun 2021